Percutaneous Left Atrial Appendage Closure Following Transcatheter Aortic Valve Replacement: Results from The ATTRACTIVE Study

References

• Leon MB , Smith CR , Mack MJ , et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med . 2016;374:1609–1620. doi:10.1056/NEJMoa1514616.
   PubMed Web of Science ®Google Scholar
• Kodali SK , Williams MR , Smith CR , et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med . 2012;366:1686–1695. doi:10.1056/NEJMoa1200384.
   PubMed Web of Science ®Google Scholar
• Vavuranakis M , Kolokathis AM , Vrachatis DA , et al. Atrial fibrillation during or after TAVI: incidence, implications and therapeutical considerations. Curr Pharm Des . 2016;22:1896–1903.
   Web of Science ®Google Scholar
• Genereux P , Cohen DJ , Mack M , et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol . 2014;64:2605–2615. doi:10.1016/j.jacc.2014.04.008.
   PubMed Web of Science ®Google Scholar
• Chow DH , Bieliauskas G , Sawaya FJ , et al. A comparative study of different imaging modalities for successful percutaneous left atrial appendage closure. Open Heart . 2017;4(2):e000627. doi:10.1136/openhrt-2017-000627.
   PubMed Web of Science ®Google Scholar
• Gafoor S , Heuer L , Franke J , et al. Transcatheter aortic valve replacement and left atrial appendage occlusion – a stitch in time? Interv Cardiol Rev . 2014;9(2):126–129. doi:10.15420/icr.2011.9.2.126.
   Google Scholar
• Fountain RB , Holmes DR , Chandrasekaran K , et al. The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial. Am Heart J . 2006;151:956–961. doi:10.1016/j.ahj.2005.10.019.
   Web of Science ®Google Scholar
• Holmes DR , Kar S , Price MJ. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol . 2014;64:1–12. doi:10.1016/j.jacc.2014.04.008.
   PubMed Web of Science ®Google Scholar
• Hansson NC , Grove EL , Andersen HR , et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol . 2016;68:2059–2069. doi:10.1016/j.jacc.2016.08.010.
   PubMed Web of Science ®Google Scholar
• Latib A , Naganuma T , Abdel-Wahab M , et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv . 2015;8:e001779.
   PubMed Web of Science ®Google Scholar
• Yanagisawa R , Hayashida K , Yamada Y , et al. Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. JACC: Cardiovasc Imaging . 2017;10(1):12–14.
   Web of Science ®Google Scholar
• Attinger-Toller A, Maisano F, Senn O, et al. “One stop shop”: safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion. J Am Coll Cardiol Intv . 2016;9:1487–95.
   Google Scholar